Related Experiment Video
Updated: Jan 2, 2026
03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
887
Metastatic thymic carcinoid: a case report
Charles C Talton1, Judith O Hopkins, Bruce D Walley
1Division of General and Thoracic Surgery, Wake Forest University School of Medicine, North Carolina Baptist Hospital, Winston-Salem, North Carolina, USA.
The American Surgeon
|August 11, 2005
Summary
Thymic carcinoid tumors are rare and aggressive. This case highlights the importance of aggressive surgery and adjuvant therapies for recurrent thymic neuroendocrine carcinoma, even in young patients.
Area of Science:
- Oncology
- Endocrinology
Background:
- Thymic neuroendocrine carcinomas (carcinoids) are rare malignancies with high metastatic potential.
- These tumors can present with associated endocrinopathies, such as Cushing syndrome.
Observation:
- A 19-year-old patient was diagnosed with thymic carcinoid and Cushing syndrome.
- Despite complete surgical resection, the patient experienced local recurrence and distant metastases to the brain, lungs, and bone.
Findings:
- The case illustrates the aggressive nature and propensity for recurrence of thymic carcinoid tumors.
- Treatment involved chemotherapy, radiotherapy, and novel agents like an antiangiogenesis agent and a tyrosine kinase inhibitor.
Implications:
- Aggressive surgical management is crucial for thymic neuroendocrine carcinomas due to their recurrence potential.
- Adjuvant therapies, including novel agents, may play a role in managing advanced or recurrent disease.
